Glutamate as a neurotransmitter in the brain: Review of physiology and pathology

Journal of Nutrition

Volumn 130, Issue 4 SUPPL., 2000, Pages

  Meldrum, Brian S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cerebral ischemia; Domoate; Excitotoxicity; Glutamate; Neuroprotection

Indexed keywords

AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DOMOIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; IONOTROPIC RECEPTOR; KAINIC ACID DERIVATIVE; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER;

AMNESIA; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY; BRAIN INJURY; BRAIN ISCHEMIA; COMPLEX PARTIAL SEIZURE; CONFERENCE PAPER; DIETARY INTAKE; EPILEPTIC STATE; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; HYPERALGESIA; NERVE CELL EXCITABILITY; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PSYCHOSIS; SECOND MESSENGER;

ANIMALIA; MYTILUS EDULIS;

EID: 0034065936     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/130.4.1007s     Document Type: Conference Paper

References (107)

1. Alexi, T., Hughes, P. E., Faull, R.L.M. & Williams, C. E. (1998) 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. NeuroReport 9: R57-R64.
2. Armstrong, N., Sun, Y., Chen, G. Q. & Gouaux, E. (1998) Structure of a glutamate receptor ligand-binding core in complex with kainate. Nature (Lond.) 395: 913-917.
3. Banerjee, S. P., Zuck, L. G., Yablonsky-Alter, E. & Lidsky, T. I. (1995) Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia. NeuroReport 6: 2500-2504.
4. Beal, M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31: 119-130.
5. Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J. M., Storey, E., Srivastava, R., Rosen, B. R. & Hyman, B.T. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid, J. Neurosci. 13: 4181-4192.
6. Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J. & Martin, J. B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature (Lond.) 321: 169-171.
7. Ben-Ari, Y., Tremblay, E., Ottersen, O.-P. & Meldrum, B. S. (1980) The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res. 192: 399-412.
8. Birnbaumer, L., Campbell, K. P., Catterall, W. A., Harpold, M. M., Hofmann, F., Horne, W. A., Mori, Y., Schwartz, A., Snutch, T. P., Tanabe, T. & Tsien, R. W. (1994) The naming of voltage-gated calcium channels. Neuron 13: 505-506.
9. Bordi, F., Pietra, C., Ziviani, L. & Reggiani, A. (1997) The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat. Exp. Neurol. 145: 425-433.
10. Boss, V., Nutt, K. M. & Conn, P. J. (1994) L-Cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity. Mol. Pharmacol. 45: 1177-1182.
11. Bristow, L. J., Flatman, K. L., Hutson, P. H., Kulagowski, J. J., Leeson, P. D., Young, L. & Tricklebank, M. (1996) The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents. J Pharmacol. Exp. Therap. 277: 578-585.
12. Bruno, V., Battaglia, G., Casabona, G., Copani, A., Caciagli, F. & Nicoletti, F. (1998a) Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor β. J. Neurosci. 18: 9594-9600.
13. Bruno, V., Sureda, F. X., Storto, M., Casdabona, G., Caruso, A., Knopfel, T., Kuhn, R. & Nicoletti, F. (1997) The neuroprotective activity of Group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal interaction. J. Neurosci. 17: 1891-1897.
14. Bruno, V., Wroblewska, B., Wroblewska, J. T., Fiore, L. & Nicoletti, F. (1998b) Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Neuroscience 3: 751-757.
15. Chapman, A. G., Smith, S. E. & Meldrum, B. S. (1991) The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res. 9: 92-96.
16. Chapman, A. G., Naran, K., Yip, P. & Meldrum, B. S. (1999a) Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine. Eur. J. Pharmacol. 383: 23-27.
17. Chapman, A. G., Yip, P. K., Yap, J. S., Quinn, L. P., Tang, E., Harris, J. R. & Meldrum B. S. (1999b) Anticonvulsant action of two antagonists at mGluR1: LY367385 ((+)-2-methyl-4-carboxyphenylglycine) and (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA) Eur. J. Pharmacol. 368: 17-24.
18. Conn, P. J. & Pin, J. P. (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37: 205-237.
19. Conti, F., DeBiasi, S., Minelli, A., Rothstein, J. D. & Melone, M. (1998) EAAC-1, a high-affinity glutamate transporter, is localized to astrocytes and GABAergic neurons besides pyramidal cells in the rat cerebral cortex. Cerebral Cortex 8: 108-116.
20. Curtis, D. R. & Watkins, J. C. (1960) The excitation and depression of spinal neurones by structurally related amino acids. J. Neurochem. 6: 117-141.
21. Dingledine, R. & Conn, J. P. (2000) Peripheral glutamate receptors: molecular biology and role in taste sensation. J. Nutr. 130: 1039S-1042S.
22. Faden, A. I., Ivanova, S. A., Yakovlev, A. G. & Mukhin, A. G. (1997) Neuroprotective effects of group III mGluR in traumatic neuronal injury. J. Neurotrauma 14: 885-895.
23. Fiorillo, C. D. & Williams, J. T. (1998) Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature (Lond.) 394: 78-82.
24. Gill, R. (1994) The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc. Brain Metab. Rev. 6: 225-256.
25. Goff, D. C. & Wine, L. (1997) Glutamate in schizophrenia: clinical and research implications. Schizophr. Res. 27: 157-168.
26. Gotti, B., Benavides, J., McKenzie, E. T. & Scatton B. (1990) The pharmacotherapy of focal cortical ischemia in the mouse. Brain Res. 522: 290-307.
27. Grotta, J., Clark, W., Coull, B., Pettigrew, L. C., Mackay, B., Goldstein, L. B., Meissner, I., Murphy, D. & LaRue, L. (1995) Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke: results of a phase IIa randomized trial. Stroke 26: 602-605.
28. Gundersen, V., Chaudry, F. A., Bjaalie, J. G., Fonnum, F., Ottersen, O.-P. & Storm-Mathisen, J. (1998) Synaptic vesicular localization and exocytosis of L-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus. J. Neurosci. 18: 6059-6070.
29. Hack, N. & Balázs, R. (1994) Selective stimulation of exitatory amino acid receptor subtypes and the survival of granule cells in culture: effect of quisqualate and AMPA. Neurochem. Int. 25: 235-241.
30. Harata, N., Katayama, J. & Akaike, N. (1999) Excitatory amino acid responses in relay neurons of the rat lateral geniculate nucleus. Neuroscience 89: 109-125.
31. Hayashi, T. (1952) A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Jpn. J. Physiol. 3: 46-64.
32. Hayashi, T., Umemori, H., Mishina, M. & Yamamoto, T. (1999) The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature (Lond.) 397: 72-76.
33. Helton, D. R., Tizzano, J. P., Monn, J. A., Schoepp, D. D. & Kallman, M. J. (1998) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 284: 651-660.
34. Hirata, A., Nakamura, R., Kwak, S., Nagata, N. & Kamakura, K. (1997) AMPA receptor-mediated slow neuronal death in the rat spinal cord induced by long-term blockade of glutamate transporters with THA. Brain Res. 771: 37-44.
35. Hollmann, M. & Heinemann, S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17: 31-108.
36. Hollmann, M., O'Shea-Greenfield, A., Rogers, S. W. & Heinemann, S. (1989) Cloning by functional expression of a member of the glutamate receptor family. Nature (Lond.) 342: 643-648.
37. Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L. & Olney, J. W. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (Washington, DC) 283: 70-74.
38. Jarrard, L. E & Meldrum, B. S. (1993) Selective excitotoxic pathology in the rat hippocampus. Neuropathol. Appl. Neurobiol. 19: 381-389.
39. Johnson, J. W. & Ascher, P. (1992) Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neurons. J. Physiol. (Lond.) 455: 339-365.
40. Kataoka, Y, Morii, H., Watanabe, Y. & Ohmori H. (1997) A postsynaptic excitatory amino acid transporter with chloride conductance functionally regulated by neuronal activity in cerebellar Purkinje cells. J. Neurosci. 17: 7017-7024.
41. Keinanen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B. & Seeburg, P. H. (1990) A family of AMPA-selective glutamate receptors. Science (Washington, DC) 249: 556-560.
42. Knapp, A. G., Matthews, L. I., & Gamzu, E. R. (1997) Clinical experience with the NMDA ion-channel blocker, Aptiganel hydrochloride (Cerestat). In: Excitatory Amino Acids: Clinical Results with Antagonists (Herrling, P. L., ed.), pp. 31-42. Academic Press, San Diego, CA.
43. Kristensen, J. D. (1997) Intrathecal administration of a competitive NMDA receptor antagonist for pain treatment. In: Excitatory Amino Acids: Clinical Results with Antagonists (Herrling, P. L., ed.), pp. 23-30. Academic Press, San Diego, CA.
44. Kristensen, J. D., Svensson, B. & Gordh, T., Jr. (1992) The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51: 249-253.
45. Lacomblez, L., Bensimon, G., Leigh, P. N., Guillet, P. & Meininger, V. (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347: 1425-1431.
46. Lam, H.-M., Chiu, J., Hsieh, M.-H., Meisel, L. Oliveira, I. C., Shin, M. & Coruzzi, G. (1998) Glutamate-receptor genes in plants. Nature (Lond.) 396: 125-126.
47. Laube, B., Kuhse, J. & Betz, H. (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18: 2954-2961.
48. Laurie, D. J., Bartke, I., Schoepfer, R., Naujoks, K. & Seeburg, P. H. (1997) Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Mol. Brain Res. 51: 23-32.
49. Lehre, K. P. & Danbolt, N. C. (1998) The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 18: 8751-8757.
50. Leigh, P. N. & Meldrum, B .S. (1996) Excitotoxicity in amyotrophic lateral sclerosis. Neurology 47: S221-S227.
51. +-dependent glutamate uptake. J. Neurosci. 19: 9620-9628.
52. Li, H., & Rogawski, M. A. (1998) GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro. Neuropharmacology 37: 1279-1286.
53. Lomeli, H., Mosbacher, J., Melcher, T., Höger, T., Geiger, J.R.P., Kuner, T., Monyer, H., Higuchi, M., Bach, A. & Seeburg, P. H. (1994) Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science (Washington, DC) 266: 1709-1713.
54. Ludolph, A. C., Meyer, T., Riepe, M. W. & Völkel, H. (1998) Amyotrophic lateral sclerosis and glutamate. Restor. Neural. Neurosci. 13: 59-67.
55. Lujan, R., Nusser, Z., Roberts, J.D.B., Shigemoto, R. & Somogyi, P. (1996) Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 8: 1488-1500.
56. Lujan, R., Roberts, J.D.B., Shigemoto, R., Ohishi, H. & Somogyi, P. (1997) Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1a, mGluR2 and mGluR5, relative to neurotransmitter release sites. J. Chem. Neuroanat. 13: 219-241.
57. Lynch, G., Granger, R., Ambros-Ingerson, J., Davis, C. M., Kessler, M. & Schehr, R. (1997) Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans. Exp. Neurol. 145: 89-92.
58. Matsui, T., Sekiguchi, M., Hashimoto, A., Tomita, U., Nishikawa, T. & Wada, K. (1995) Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J. Neurochem. 65: 454-458.
59. Mayer, M. L., Benveniste, M. & Patneau D. K. (1994) NMDA receptor agonists and competitive antagonists In: The NMDA Receptor (Collingridge, G. J. & Watkins, J. C., eds.), pp. 132-146. Oxford University Press, Oxford, UK.
60. McDonald, J. W. & Schoepp, D. D. (1992) The metabotropic excitatory amino acid receptor agonist 1 S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury. Eur. J. Pharmacol. 215: 353-354.
61. Meldrum, B. S. (1990) Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2: 27-57.
62. Meldrum, B. (1993) Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders. Brain Res. Rev. 18: 293-314.
63. Meldrum, B. S. (1998) The glutamate synapse as a therapeutic target: perspectives for the future. In: Progress in Brain Research (Ottersen, O. P., Langmoen, I. A. & Gjerstad, L., eds.), vol. 116, pp. 413-430. Elsevier Science B. V., Amsterdam, The Netherlands.
64. Meldrum, B. S. & Chapman, A. G. (1999) Excitatory amino acid receptors and antiepileptic drug development. In: Advances in Neurology (Delgado-Escueta, A. V., Wilson, W. A., Olsen, R. W. & Porter, R. J., eds.). Vol. 79, pp. 965-978. Lippincott Williams & Wilkins, Philadelphia, U.S.A.
65. Meldrum, B. & Garthwaite, J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. In: Trends in Pharmacological Sciences, pp. 379-387, Elsevier Science Ltd., Cambridge, UK.
66. Mitani, A., Watanabe, M. & Kataoka, K. (1998) Functional change of NMDA receptors related to enhancement of susceptibility to neurotoxicity in the developing pontine nucleus. J. Neurosci. 18: 7941-7952.
67. Moghaddam, B. & Adams, B. W. (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science (Washington, DC) 281: 1349-1352.
68. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B. & Seeburg, P. H. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (Washington, DC) 256: 1217-1221.
69. Mukhin, A., Fan, L. & Faden, A. I. (1996) Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury. J. Neurosci. 16: 6012-6020.
70. Obrenovitch, T. P. & Urenjak, J. (1997) Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51: 39-87.
71. Okiyama, K., Smith, D. H., White, W. F., Richter, K. & McIntosh, T. K. (1997) Effects of the novel NMDA antagonists CP-98,113, CP-101, 581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat. J. Neurotrauma 14: 211-222.
72. Olney, J. W. (1971) Glutamate-induced neuronal necrosis in the infant mouse ypothalamus: an electron microscopic study. J. Neuropathol. Exp. Neurol. 30: 75-90.
73. Olney, J. W. (1983) Excitotoxins: an overview. In: Excitotoxins (Fuxe, K., Roberts, P. & Schwarcz, R., eds.), pp. 82-96. Macmillan Press, London, UK.
74. Olney, J. W., Ho, O. C. & Rhee, V. (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp. Brain Res. 14: 61-76.
75. Olney, J. W., Sharpe, L G. & Feigin, R D. (1972) Glutamate-induced brain damage in infant primates. J. Neuropathol. Exp. Neurol. 16: 464-488.
76. O'Neill, M. J., Bond, A., Ornstein, P. L., Ward, M. A., Hicks, C. A., Hoo, K., Bleakman, D. & Lodge, D. (1998) Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology 37: 1211-1222.
77. Orlando, L. R., Luthi-Carter, R., Standaert, D. G., Coyle, J. T., Penney, J. B., Jr. & Young, A. B. (1997) N-Acetylaspartylglutamate (NAAG) protects against rat striatal quinolinic acid lesions in vivo. Neurosci. Lett. 236: 91-94.
78. Pin, J.-P. & Duvoisin, R. (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34: 1-26.
79. Ren, R. F. & Flanders, K. C. (1996) Transforming growth factors β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid. Brain Res. 732: 16-24.
80. Rodriguez-Moreno, A. & Lerma, J. (1998) Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 20: 1211-1218.
81. Rothstein, J. D. & Kuncl, R. W. (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65: 643-651.
82. Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L J. & Kuncl, R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38: 73-84.
83. Roy, J., Minotti, S., Dong, L., Figlewicz, D. A. & Durham, H. D. (1998) Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J. Neurosci. 18: 9673-9684.
84. Sacaan, A. I. & Schoepp, D. D. (1992) Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci. Lett. 139: 77-82.
85. Sagara, Y. & Schubert, D. (1998) The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci. 18: 6662-6671.
86. Schauwecker P. E. & Steward, O. (1997) Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl. Acad. Sci. U.S.A. 94: 4103-4108.
87. Schmutz, M., Arthur, A., Faleck, H., Karlsson, G., Kotake, A., Lantwicki, L., LaRue, L., Markabi, S., Murphy, D., Powell, M. & Sauer, D. (1997) Selfotel (CGS19755). In: Excitatory Amino Acids: Clinical Results with Antagonists (Herrling, P. L., ed.), pp. 1-6. Academic Press, San Diego, CA.
88. Schoepp, D. D. & Conn, P. J. (1993) Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 14: 13-20.
89. Schulz, J. B., Matthews, R. T., Henshaw, D. R. & Beal, M. F. (1996) Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience 71:1043-1048.
90. Schwarcz, R., Whetsell, W. O. & Mangano, R. M. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (Washington, DC) 219: 316-318.
91. Seal, R. P. & Amara, S. G. (1999) Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39: 431-456.
92. Shigemoto, R., Kulik, A., Roberts, J.D.B., Ohishi, H., Musse, Z., Kaneko, T. & Somogyi, P. (1996) Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone. Nature (Lond.) 381: 523-525.
93. Shors, T. J., Servatius, R. J., Thompson, R. F., Rogers, G. & Lynch, G. (1995) Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat. Neurosci. Lett. 186: 153-156.
94. Spencer, P. S., Ludolph, A., Dwivedi, M. P., Roy, D. N., Hugon, J. & Schaumburg, H. H. (1986) Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet 1066-1067.
95. Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N. & Robertson, R.C. (1987) Guam amyotrophic lateral sclerosis-Parkinsonism-dementia linked to a plant excitant neurotoxin. Science (Washington, DC) 237: 517-522.
96. Stephens, D. N., Meldrum, B. S., Weidmann, R., Schneider, C. & Grutzner, M. (1986) Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology 90: 166-169.
97. Sveinbjornsdottir, S., Sander, J.W.A.S., Upton, D., Thompson, P. J., Patsalos, P. N., Hirt, D., Emre, M., Lowe, D. & Duncan, J. S. (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res. 16: 165-174.
98. Teitelbaum, J. S., Zatorre, R. J., Carpenter, S., Gendron, D., Evans, A. C, Gjedde, A. & Cashman N. R. (1990) Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Engl. J. Med. 322: 1781-1787.
99. Thompson, G. A. & Kilpatrick, I. C. (1996) The neurotransmitter candidature of sulphur-containing excitatory amino acids in the mammalian central nervous system. Pharmacol. Ther. 72: 25-36.
100. Thomsen, C. & Suzdak, P. D. (1993) Serine-O-phosphate has affinity for type IV, but not type 1, metabotropic glutamate receptor. NeuroReport 4: 1099-1101.
101. Toulmond, S., Serrano, A., Benavides, J. & Scatton, B. (1993) Prevention by Eliprodil (SL 820715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window. Brain Res. 620: 32-41.
102. Ullensvang, K., Lehre, K. P., Storm-Mathisen, J. & Danbolt, N. C. (1997) Differential developmental expression of the two rat brain glutamate transporter proteins GLAST and GLT. Eur. J. Neurosci. 9: 1646-1655.
103. Van den Pol, A. N., Hermans-Borgmeyer, I., Hofer, M., Ghosh, P. & Heinemann, S. (1994) Ionotropic glutamate-receptor gene expression in hypothalamus: localization of AMPA, kainate, and NMDA receptor RNA with in situ hybridization. J. Comp. Neurol. 343: 428-444.
104. 3 of the rat hippocampus. Neuropharmacology 37: 1269-1277.
105. Weiss, J. H. & Choi, D. W. (1988) β-N-Methylamino-L-alanine neurotoxicity: requirement for bicarbonate as a cofactor. Science (Washington, DC) 241: 973-975.
106. Willis, C. L., Meldrum, B. S., Nunn, P. B., Anderton, B.H. & Leigh, P. N. (1993) Neuronal damage induced by β-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Brain Res. 627: 55-62.
107. Yano, S., Tokumitsu, H. & Soderling, T. R. (1998) Calcium promotes cell survival through CaM-k kinase activation of the protein-kinase-B pathway. Nature (Lond.) 396: 584-587.